Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
Takehiro Kawashiri, Keisuke Mine, Daisuke Kobayashi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1393-1393
Open Access | Times Cited: 21

Showing 21 citing articles:

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
Takehiro Kawashiri, Mizuki Inoue, Kohei Mori, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8733-8733
Open Access | Times Cited: 27
Repurposing bosentan as an anticancer agent: EGFR/ERK/c‐Jun modulation inhibits NSCLC tumor growth
Marwa M. Khalaf, Marina N. Malak, Tariq G. Alsahli, et al.
Fundamental and Clinical Pharmacology (2025) Vol. 39, Iss. 1
Closed Access
Lentinula edodes mycelia extract abrogates chemotherapy-evoked cold and mechanical allodynia in mice
Masanobu Tsubaki, Natsuki Kato, Keisuke Tateishi, et al.
Future Journal of Pharmaceutical Sciences (2025) Vol. 11, Iss. 1
Open Access
Inorganic chemical biology and metal complexes in cells: from the design of cellular models to evaluate antioxidant activity to the characterization of metal complexes in cells
Clotilde Policar, Christine Rampon, Alice Balfourier, et al.
Comptes Rendus Chimie (2025) Vol. 28, Iss. G1, pp. 397-421
Open Access
α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy
I. A. Dyachenko, Yu. A. Palikova, В. А. Паликов, et al.
Biochimie (2022) Vol. 194, pp. 127-136
Closed Access | Times Cited: 17
Emodin suppresses oxaliplatin‐induced neuropathic pain by inhibiting COX2/NF‐κB mediated spinal inflammation
He‐Yu Yang, Ji Wu, Hong Lu, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 37, Iss. 1
Closed Access | Times Cited: 14
The effects of mesenchymal stem cells on the chemotherapy of colorectal cancer
Meiqi Wang, Jiannan Li, Dong‐Xin Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114373-114373
Open Access | Times Cited: 8
Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
Siyu Peng, Ariel Fangting Ying, Nicholas Jian Hao Chan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Synthesis and Characterization of Chitosan Acetylcholine Nanoparticles for Neural Disorders Associated with Cancer Treatment
Mamilla Ravi Sankar, R. Karthikeyan, S. Vigneshkumar
Journal of Inorganic and Organometallic Polymers and Materials (2023) Vol. 33, Iss. 8, pp. 2465-2484
Closed Access | Times Cited: 6
Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication
Xiaowei Wang, Mengyan Wang, Meilian Cai, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4477-4501
Open Access | Times Cited: 6
Antioxidant and Neuroprotective Effect of a Grape Pomace Extract on Oxaliplatin-Induced Peripheral Neuropathy in Rats: Biochemical, Behavioral and Histopathological Evaluation
Chryssa Bekiari, Fotios Tekos, Zoi Skaperda, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 7
Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
Xiaoli Lv, Yingwei Mao, Song Cao, et al.
Ibrain (2022) Vol. 9, Iss. 1, pp. 72-89
Open Access | Times Cited: 7
Preparation of Enantiopure 3-Aminopiperidine and 3-Aminoazepane Derivatives from Ornithine and Lysine. Consecutive Syntheses of Pharmacologically Active Analogs, Such as Besifloxacin
Ingo Schiffers, Marcus Frings, Britta Maria Kübber, et al.
Organic Process Research & Development (2022) Vol. 26, Iss. 10, pp. 2811-2822
Closed Access | Times Cited: 5
Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study
S. Yokoyama, Chihiro NAKAGAWA, Kouichi Hosomi
Supportive Care in Cancer (2021) Vol. 30, Iss. 2, pp. 1765-1773
Closed Access | Times Cited: 7
Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database
Keisuke Mine, Takehiro Kawashiri, Mizuki Inoue, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8859-8859
Open Access | Times Cited: 4
Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
Nobuaki Egashira
Frontiers in Pain Research (2021) Vol. 2
Open Access | Times Cited: 5
Treatment Strategy of Oxaliplatin-induced Peripheral Neuropathy: A Retrospective, Nationwide Study
S. Yokoyama, Chihiro NAKAGAWA, Kouichi Hosomi
Research Square (Research Square) (2021)
Closed Access | Times Cited: 4
Protective Effects of Boswellia and Curcuma Extract on Oxaliplatin-Induced Neuropathy via Modulation of NF-κB Signaling
Sakshi Mahajan, Varun Sureja, Dharmeshkumar Kheni, et al.
Toxicology Reports (2024) Vol. 13, pp. 101781-101781
Open Access
Development of a Novel Microphysiological System for Peripheral Neurotoxicity Prediction Using Human iPSC-Derived Neurons with Morphological Deep Learning
Xiaobo Han, Naoki Matsuda, Makoto Yamanaka, et al.
Toxics (2024) Vol. 12, Iss. 11, pp. 809-809
Open Access
Does statin suppress oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer? A single-center observational study
Kazuaki Okamoto, Hiroaki Nozawa, Shigenobu Emoto, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 11
Open Access | Times Cited: 1
Impact of the Rutin on Diabetic Complications
Yash Kumar Gaur, Shivendra Kumar, Jeetendra Kumar Gupta, et al.
Current Functional Foods (2023) Vol. 2, Iss. 1
Closed Access
Page 1

Scroll to top